Chemical Society Reviews,
Journal Year:
2023,
Volume and Issue:
52(14), P. 4672 - 4724
Published: Jan. 1, 2023
This
review
discusses
the
strengths
and
shortcomings
of
different
strategies
to
facilitate
NP
transport
across
barriers
organs
highlights
key
findings
that
can
stimulate
further
advances
in
this
field.
Accounts of Chemical Research,
Journal Year:
2023,
Volume and Issue:
56(12), P. 1578 - 1590
Published: May 23, 2023
ConspectusTheranostic
nanoparticles'
potential
in
tumor
treatment
has
been
widely
acknowledged
thanks
to
their
capability
of
integrating
multifaceted
functionalities
into
a
single
nanosystem.
Theranostic
nanoparticles
are
typically
equipped
with
an
inorganic
core
exploitable
physical
properties
for
imaging
and
therapeutic
functions,
bioinert
coatings
improved
biocompatibility
immunological
stealth,
controlled
drug-loading–release
modules,
the
ability
recognize
specific
cell
type
uptake.
Integrating
multiple
nanosized
construct
require
sophisticated
molecular
design
precise
execution
assembly
procedures.
Underlying
multifunctionality
theranostic
nanoparticles,
ligand
chemistry
plays
decisive
role
translating
theoretical
designs
fully
functionalized
nanoparticles.
The
hierarchy
is
usually
threefold.
As
they
serve
passivate
nanoparticle's
surface,
capping
ligands
form
first
layer
directly
interfacing
crystalline
lattice
core.
size
shape
largely
determined
by
property
so
that
have
profound
influences
on
surface
properties.
Capping
mostly
chemically
inert,
which
necessitates
presence
additional
drug
loading
targeting.
second
commonly
utilized
loading.
Therapeutic
drugs
can
either
be
covalently
conjugated
onto
or
noncovalently
loaded
via
drug-loading
ligands.
Drug-loading
need
equally
versatile
accommodate
diversity
drugs.
Biodegradable
moieties
often
incorporated
enable
smart
release.
With
aid
targeting
stand
tallest
nanoparticle
seek
bind
corresponding
receptors
target,
preferentially
accumulate
at
site
attain
higher
precision
quantity
delivery.
In
this
Account,
utilities
representative
ligands,
reviewed.
Since
these
types
assembled
close
vicinity
each
other,
it
essential
them
compatible
able
function
tandem
other.
Relevant
conjugation
strategies
critical
factors
significant
impact
ligands'
performance
discussed.
Representative
presented
showcase
how
different
synergistically
from
Finally,
technological
outlook
evolving
provided.
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
374, P. 219 - 229
Published: Aug. 16, 2024
Nanoparticles
(NPs)
can
be
designed
for
targeted
delivery
in
cancer
nanomedicine,
but
the
challenge
is
a
low
efficiency
(DE)
to
tumor
site.
Understanding
impact
of
NPs'
physicochemical
properties
on
target
tissue
distribution
and
DE
help
improve
design
nanomedicines.
Multiple
machine
learning
artificial
intelligence
models,
including
linear
regression,
support
vector
machine,
random
forest,
gradient
boosting,
deep
neural
networks
(DNN),
were
trained
validated
predict
based
therapeutic
strategies
with
dataset
from
Nano-Tumor
Database.
Compared
other
DNN
model
had
superior
predictions
tumors
major
tissues.
The
determination
coefficients
(R
ACS Applied Materials & Interfaces,
Journal Year:
2023,
Volume and Issue:
15(21), P. 25324 - 25338
Published: May 16, 2023
Although
nanoparticle-based
chemotherapeutic
strategies
have
gained
in
popularity,
the
efficacy
of
such
therapies
is
still
limited
part
due
to
different
nanoparticle
sizes
needed
best
accommodate
parts
drug
delivery
pathway.
Herein,
we
describe
a
nanogel-based
nanoassembly
based
on
entrapment
ultrasmall
starch
nanoparticles
(size
10–40
nm)
within
disulfide-crosslinked
chondroitin
sulfate-based
nanogels
150–250
address
this
challenge.
Upon
exposure
reductive
tumor
microenvironment,
nanogel
can
degrade
release
doxorubicin-loaded
facilitate
improved
intratumoral
penetration.
CT26
colon
carcinoma
spheroids
could
be
efficiently
penetrated
by
(resulting
1
order
magnitude
higher
DOX-derived
fluorescence
inside
spheroid
relative
free
DOX),
while
vivo
experiments
showed
that
nanoassemblies
reduced
6×
saline
controls
and
2×
DOX
after
21
days.
Together,
these
data
suggest
are
viable
option
for
improving
safety
vehicles
treating
cancer.
Small,
Journal Year:
2023,
Volume and Issue:
19(35)
Published: May 1, 2023
Second
near
infrared
(NIR-II,
1000-1700
nm)
fluorescence
lifetime
imaging
is
a
powerful
tool
for
biosensing,
anti-counterfeiting,
and
multiplex
imaging.
However,
the
low
photoluminescence
quantum
yield
(PLQY)
of
probes
in
NIR-II
region
limits
its
data
collecting
efficiency
accuracy,
especially
molecular
vivo.
To
solve
this
problem,
lanthanide-doped
nanoparticles
(NPs)
β-NaErF4
:
2%Ce@NaYbF4
@NaYF4
with
high
PLQY
tunable
PL
through
multi-ion
doping
core-shell
structural
design,
are
presented.
The
obtained
internal
can
reach
up
to
50.1%
cyclohexane
9.2%
water
under
excitation
at
980
nm.
Inspired
by
above
results,
fast
whole-body
vascular
mice
successfully
performed
using
homebuilt
system,
which
reveals
murine
abdominal
capillary
network
background.
A
further
demonstration
carried
out
atherosclerosis
cells
different
organs
vivo
NPs
conjugating
specific
peptides
injection
modalities,
respectively.
These
results
demonstrate
that
combined
system
realize
signal-to-noise
imaging;
thus,
opening
road
atherosclerosis.
Journal of Functional Biomaterials,
Journal Year:
2023,
Volume and Issue:
14(6), P. 290 - 290
Published: May 24, 2023
Bioactive
nanomaterials
are
increasingly
being
applied
in
oral
health
research.
Specifically,
they
have
shown
great
potential
for
periodontal
tissue
regeneration
and
substantially
improved
translational
clinical
applications.
However,
their
limitations
side
effects
still
need
to
be
explored
elucidated.
This
article
aims
review
the
recent
advancements
discuss
future
research
directions
this
field,
especially
focusing
on
using
improve
health.
The
biomimetic
physiochemical
properties
of
such
as
metals
polymer
composites
described
detail,
including
alveolar
bone,
ligament,
cementum
gingiva.
Finally,
biomedical
safety
issues
application
regenerative
materials
updated,
with
a
discussion
about
complications
perspectives.
Although
applications
bioactive
cavity
at
an
initial
stage,
pose
numerous
challenges,
suggests
that
promising
alternative
regeneration.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: May 9, 2024
Abstract
Background
Active
targeting
by
surface-modified
nanoplatforms
enables
a
more
precise
and
elevated
accumulation
of
nanoparticles
within
the
tumor,
thereby
enhancing
drug
delivery
efficacy
for
successful
cancer
treatment.
However,
surface
functionalization
involves
complex
procedures
that
increase
costs
timelines,
presenting
challenges
clinical
implementation.
Biomimetic
(BNPs)
have
emerged
as
unique
platforms
overcome
limitations
actively
targeted
nanoparticles.
Nevertheless,
BNPs
coated
with
unmodified
cells
show
reduced
functionalities
such
specific
tumor
targeting,
decreasing
therapeutic
efficacy.
Those
can
be
engineering
non-patient-derived
BNP
coating,
but
these
are
cost-effective
approaches
hinder
their
wider
application.
Here
we
present
an
immune-driven
strategy
to
improve
nanotherapeutic
tumors.
Our
perspective
harnesses
T-cell
exhaustion
immune
evasion
develop
groundbreaking
new
class
crafted
from
exhausted
T-cells
(NExT)
triple-negative
breast
(TNBC)
patients
culture
methods
without
sophisticated
engineering.
Methods
NExT
were
generated
coating
PLGA
(poly(lactic-co-glycolic
acid))
TNBC-derived
in
vitro
acute
activation.
Physicochemical
characterization
was
made
dynamic
light
scattering,
electrophoretic
scattering
transmission
electron
microscopy,
preservation
orientation
checkpoint
receptors
flow
cytometry.
The
chemotherapy-loaded
assessed
TNBC
cell
lines
vitro.
In
vivo
toxicity
CD1
mice.
Biodistribution
activity
determined
cell-line-
autologous
patient-derived
xenografts
immunodeficient
Results
We
report
approach
good
performance
provides
naturally
endowed
(PD1,
LAG3,
TIM3),
augmenting
engaging
cognate
ligands,
chemotherapy,
disrupting
PD1/PDL1
axis
immunotherapy-like
way.
Autologous
revealed
exceptional
intratumor
accumulation,
heightened
chemotherapeutic
index
efficiency,
stroma
PDL1
+
xenograft
model
cancer.
Conclusions
These
advantages
underline
potential
revolutionize
tailored
adoptive
nanotherapy
chemoimmunotherapy,
which
endorses
widespread
application
NExT.